论文部分内容阅读
世界上大约有3亿乙型肝炎表面抗原(HBsAg)携带者。感染乙肝的成年人5%～10%转变为慢性,其中10%经过肝硬化,最终发展为肝细胞肝癌。主动乙肝疫苗接种95%产生抗乙型肝炎病毒(HBV)感染的抗体。最初从人血清中获取的乙肝主动免疫疫苗于1982年投放市场,1986年出现了
There are about 300 million Hepatitis B surface antigen (HBsAg) carriers in the world. Adults infected with hepatitis B 5% to 10% into chronic, of which 10% of cirrhosis, the ultimate development of hepatocellular carcinoma. Active hepatitis B vaccination 95% Antibodies against hepatitis B virus (HBV) infection. The hepatitis B active immunization vaccine originally obtained from human serum was put on the market in 1982 and appeared in 1986